California Last-Mile Delivery Contractor Adds Workhorse W56 Step Van to Fleet
Newsfilter· 2024-08-02 20:30
CINCINNATI, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) ("Workhorse" or "the Company"), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced the first delivery of its W56 step van as part of an ongoing collaboration with NorCal Transports Inc. ("NorCal"), a last-mile package delivery contractor in Richmond, California. The delivery, facilitated through Workhorse's Certified Dealer, Kingsburg Truck Sales, provides ...
Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
Newsfilter· 2024-08-02 20:30
公司财务报告与会议安排 - 制药公司Optinose将于2024年8月8日股市开盘前公布2024年第二季度财务业绩和公司最新情况 [1] - 公司领导团队成员将在2024年8月8日美国东部时间上午8:00主持电话会议讨论财务结果和公司更新 [2] 会议参与方式 - 参与者可通过访问Optinose网站投资者板块http://ir.optinose.com/event - calendar进行网络直播参会 [3] - 如需电话参会需提前在指定链接注册,注册后将收到包含拨入号码和个人识别码的确认邮件以参会 [3] - 会议结束后60天内可在公司网站观看网络直播回放 [3] 公司概况 - Optinose是一家专业制药公司专注于满足耳鼻喉科和过敏专科医生护理患者的需求 [4] - 可通过www.optinose.com或在X和LinkedIn上关注公司了解更多信息 [4] - 公司投资者联系人是Jonathan Neely联系方式为jonathan.neely@optinose.com或267.521.0531 [4]
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
Newsfilter· 2024-08-02 20:30
THE WOODLANDS, TX, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the next CEO Corner segment has been published on the Company's website. For the CEO Corner segment, Brad Hauser, CEO of Autonomix, discussed the Company's recently completed transaction with RF Innovations, Inc., a ...
Arbor Realty Trust Reports Second Quarter 2024 Results and Declares Dividend of $0.43 per Share
Newsfilter· 2024-08-02 20:15
Company Highlights: GAAP net income of $0.25 and distributable earnings of $0.45, per diluted common share1Declares cash dividend on common stock of $0.43 per shareStrong liquidity position with ~$725 million in cash and liquidity and ~$215 million of CLO restricted cash2Agency loan originations of $1.15 billion; a servicing portfolio of ~$32.28 billion, up 3%Structured loan originations of $227.2 million, runoff of $629.6 million and a portfolio of ~$11.87 billionRedeemed our 5.75% senior notes at maturity ...
BETTER CHOICE PROVIDES POSITIVE PRELIMINARY RESULTS FOR THE SECOND QUARTER OF 2024
Newsfilter· 2024-08-02 20:05
Estimates $2.7 Million Net Income for Second Quarter 2024, a 190% Increase YOY Estimates Basic EPS of $2.98 per share for Second Quarter 2024, a 170% Increase YOY Estimates Halo Breaks Even at $0.02 Million Adj. EBITDA for First Half 2024, a 101% Increase YOY* TAMPA, FL, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American: BTTR) (the "Company" or "Better Choice"), a pet health and wellness company, today announced preliminary, key financial metrics guidance for the three months and s ...
Cumulus Media Reports Operating Results for the Second Quarter 2024
Newsfilter· 2024-08-02 20:01
Completed Highly Successful Debt Exchange That Reduced Our Debt Obligations Under Our Debt Instruments by Approximately $33 Million, Extended Maturities to 2029, Obtained Favorable Interest Rates, and Preserved Structure Free of Financial Maintenance Covenants Upsized ABL Facility by 25% to $125 Million and Extended Maturity to 2029 Reported Q2 Total Revenue of $205 Million, Down 2.5%, in Line with Pacing Guidance Increased Digital Marketing Services Revenue by 24%, Total Digital Revenue by 5% ATLANTA, Aug. ...
Newmark Reports Second Quarter 2024 Financial Results
Prnewswire· 2024-08-02 20:01
Conference Call to Discuss Results Scheduled for 10:00 a.m. ET Today NEW YORK, Aug. 2, 2024 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and occupiers, today, reported its financial results for the three and six months ended June 30, 2024, and declared its quarterly dividend. A complete and full-text financial results press release, includi ...
Hanover Bancorp Announces Small Business Recovery Grants to Local Non-Profit Organizations
Newsfilter· 2024-08-02 20:00
MINEOLA, N.Y., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Michael P. Puorro, Chairman and Chief Executive Officer of Hanover Bancorp, Inc. the bank holding company for Hanover Community Bank, today announced grants to seventeen local not-for-profit organizations as a part of the Federal Home Loan Bank of New York's (FHLBNY) Small Business Recovery Grant Program. Mr. Puorro stated "These organizations are the very heartbeat of the communities we serve, and we are thrilled that this money will help them in fulfilling ...
Agrify Reminds Stockholders to Vote Before the Proxy Voting Deadline for the Upcoming Annual Meeting of Stockholders
Newsfilter· 2024-08-02 20:00
BILLERICA, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (NASDAQ:AGFY) ("Agrify" or the "Company"), the most innovative provider of advanced cultivation and extraction solutions for the cannabis industry, would like to remind stockholders to cast their votes for the proposals that will be voted on at the Company's annual meeting of stockholders (the "Meeting") in advance of the proxy voting deadline for voting by telephone or electronically of 11:59 p.m. (Eastern Daylight Time) on Sunday, Augu ...
Inspire Medical Systems, Inc. Announces FDA Approval of the Inspire V System
Newsfilter· 2024-08-02 20:00
MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced the FDA approval of the Inspire V therapy system which includes the next generation neurostimulator and the associated Bluetooth® patient remote and physician programmer. "We are thrilled to announce the FDA approval of our ...